Related Experiment Videos
HLA antigens and primary open-angle glaucoma in black Americans
Investigative Ophthalmology & Visual Science
|February 1, 1977
Summary
Human leukocyte antigen (HLA) antigen frequencies differ between Black and White patients with primary open-angle glaucoma compared to healthy individuals. These HLA antigen variations may influence glaucoma susceptibility in different racial groups.
Area of Science:
- Immunogenetics
- Ophthalmology
- Human Leukocyte Antigen (HLA) System
Background:
- Primary open-angle glaucoma (POAG) is a leading cause of irreversible blindness worldwide.
- Genetic factors, including human leukocyte antigen (HLA) genes, are implicated in POAG pathogenesis.
- Previous studies suggest racial disparities in POAG prevalence and genetic associations.
Purpose of the Study:
- To investigate the association of specific HLA antigen frequencies with POAG in Black and White patient cohorts.
- To compare HLA antigen profiles between POAG patients and healthy controls within each racial group.
- To identify potential race-specific genetic markers for POAG susceptibility.
Main Methods:
- Case-control study comparing HLA antigen frequencies.
- Analysis of HLA-A, HLA-B, and HLA-DR loci.
- Statistical comparison between patients with primary open-angle glaucoma and non-glaucomatous individuals across racial groups.
Main Results:
- Black patients with POAG showed increased HLA-B7 and HLA-B12, and decreased HLA-A1 and HLA-A11 frequencies compared to controls.
- White patients with POAG shared increased HLA-B7, HLA-B12, and decreased HLA-A11 frequencies with Black patients.
- White patients with POAG additionally exhibited increased HLA-A3 and decreased HLA-Bw35 frequencies, not observed in Black patients.
Conclusions:
- Specific HLA antigen profiles are associated with primary open-angle glaucoma in both Black and White populations.
- Distinct HLA antigen associations exist between racial groups, suggesting differential genetic contributions to POAG.
- HLA antigen typing may offer insights into the complex genetic basis of POAG and inform personalized risk assessment.